June 2025
The global bone grafts and substitutes market size accounted for USD 3.20 billion in 2024 and is predicted to increase from USD 3.38 billion in 2025 to approximately USD 5.68 billion by 2034, expanding at a CAGR of 5.94% from 2025 to 2034.
The use of artificial intelligence is transforming the bone grafts and substitutes market and making it more precise, efficient, as well as innovative at various phases of bone tissue engineering. The screening, modelling, optimisation, and synthesis of bone graft materials can be assisted by AI, and therefore, personalised solutions can be realised within a shorter time frame and with accuracy. In clinical applications, AI has been implemented in diagnostics, pre-operative planning, and post-operative monitoring, and reduces errors in human decisions and improves patient outcomes.
The U.S. bone grafts and substitutes market size was exhibited at USD 1.25 billion in 2024 and is projected to be worth around USD 2.14 billion by 2034, growing at a CAGR of 5.62% from 2025 to 2034.
Just like all the other advanced technologies the bone grafts and substitutes technology will also boom in the North American region. The North American region is expected to dominate the market in the coming years period in the past this region has held about 47.71% of the market share in terms of revenue. The availability of world class infrastructure and the availability of varied innovative products will drive the market growth. As there has been an increase in the investments for the health care activities the market will grow well. The United States is the nation that shall lead the market growth of this region. As it has been an increase in the number of injuries that were trauma-related the bone grafts and the substitutes market will grow well in the United States.
One of the most important reasons which is expected to help in the growth of the market is the increase in the cases of the joint and bone disorders. There has been a growth in the demand for bone graft for the orthopedic surgeries. Bone grafts are in great demand due to its use as an alternative in the autologous type of the bone graft. Due to an increase in the number of cases of bone defects the market for bone graft cell substitute is expected to grow during the forecast period. There is an increased demand for substitutes and bone grafts in the orthopedics for spinal fusion as well As for the union and the non-union surgery. There is an extensive use of bone grafts and substitutes for the fractured bones.
In the recent years the demand for bone grafts and substitutes has increased considerably and it is expected to grow well during the forecast period. As the cases of different types of bone diseases are increasing across many nations the market is expected to grow. Increased cases of bone infections will also help in driving the market growth during the forecast period. As there has been a great demand for different types of orthopedic surgeries and a demand for surgeries of the boomers the market for bone grafts and substitutes will grow well during the forecast period. There is an increase in the demand for though substitutes of the synthetic nature. The presence of various authorities that provide approval for the use of these synthetic substitutes will also be helpful in driving the growth of the market. There are many risks associated with the use of bone graft substitutes. There are chances of adverse reactions and sometimes the bone formation may not be complete. There are also great chances of infection. All of these factors will hamper the growth of the market during the forecast period. There are many the risks that are associated with the usage of these synthetic products the regulatory authorities have recalled many products due to its risk that would hamper the health of an individual.
U.S. Bone Grafts and Substitutes Market Trends
The U.S. bone grafts and substitutes market is projected to witness growth over the forecast period, owing to the increased prevalence of orthopedic conditions along with the surge in cases of sports-related injuries. This is the trend increasing the demand for effective bone repair products like grafts and substitutes. Moreover, the well-developed healthcare system, access to trained orthopedic surgeons, and the emphasis on the minimally invasive practice allow the extreme usage of the innovative bone graft material in the country. The constant improvement in both regenerative medicine and biomaterials, as well as the positive reimbursement policies in the United States, are additional stimulants of the market growth.
Asia Pacific Bone Grafts and Substitutes Market Trends
Asia Pacific is estimated to grow at the fastest CAGR during the forecast period. This growth has been facilitated by a number of factors, including the fact that there has been a marked increase in patient population that is subject to orthopedic diseases like osteoporosis, osteoarthritis, and traumatic fractures of bones. The growth of life expectancy, the trend towards a sedentary lifestyle, and the emergence of an increase in road accidents are also some of the factors that are causing the augmented need for effective bone regeneration solutions. Also, positive governmental efforts to increase access to healthcare, an increase in healthcare spending, and a rapidly growing number of specialty orthopedic clinics and hospitals are contributing to the development of the market.
China Bone Grafts and Substitutes Market Trends
China should be the leader of the Asia Pacific bone grafts and substitutes market, as a consequence of the aging of its people, which is gaining momentum at present and is predicted to have the greatest aging population in the world in the foreseeable future. Since aging is the leading cause of orthopedic diseases, the number of associated fractures, spinal degeneration, and bone-related diseases is likely to shoot up significantly. The cheap manufacturing capacity and the supply of skilled labor are also good factors in the country and attracting other global manufacturers to establish their manufacturing plants.
Europe Bone Grafts and Substitutes Market Trends
Europe's bone grafts and substitutes market is enjoying a significant growth rate due to an aging population, rising incidences of orthopedic and musculoskeletal disorders, and the mushrooming cases of trauma and road accidents. Disorders like osteoporosis, osteoarthritis, and degenerative disorders of joints are also becoming prevalent, especially among the elderly and post-menopausal women, and this requires the development of cell-based therapy for regenerating the bones. The high need of the region for minimally invasive procedures is also stimulating the process of using bone graft substitutes that provide faster recovery periods and less incidence of surgical complications.
Germany stands the chance of becoming one of the major growth enhancers in the European bone grafts and substitutes market. Advanced medical infrastructure, the availability of top orthopedic research centers, and close cooperation between academic centers and biotech companies in Germany are helping innovation and the development of products in the orthopedic industry. Moreover, high-quality with safe products are likely to be achieved due to strict regulatory requirements in Germany to provide better patient outcomes, and this is done by increasing patient trust in bone grafting procedures.
The bone grafts and substitutes market consists of numerous biologics as well as synthetic products designed to assist in tissue restoration, tissue repair, and tissue replacement. In the orthopedic environment and dental environment, bone grafts and substitutes rebuild the integrity of the bone and facilitate new bone development, and facilitate increased recovery.
The global bone grafts and substitutes market is expected to expand mainly due to increased cases of orthopedic disorders like osteoarthritis, rheumatoid arthritis, and osteoporosis, which require surgical treatment through bone grafting. Moreover, the old age group that is more prone to bone degeneration and fractures plays a very crucial role in influencing the growth of the market. With the enhancement of healthcare structures and awareness across the world, particularly in rising economies, the marketplace for bone grafts and substitutes will continue to witness dynamic growth.
Increased awareness regarding the availability of bone grafts and various synthetic substitutes is expected to boost the market growth during the forecast period. There is an increased use of substitutes as it helps in providing various benefits to the consumers. The use of substitute has been increased as there are very less complications associated with the use of these substitutes. The process of bone grafting is easier and preferred by the surgeons. There has been an increased use of the substitutes in different types of dental implants. There has been no growth in the demand for various substitutes that shall be helpful in increasing the thickness as well as the height of the jawbone of the patient which is extremely important in order to have effective dental implants. Various benefits associated with the use of the bone grafts substitutes will drive the market growth during the forecast period.
Constant research and development activities have provided technological advancements in the market which are expected to drive the market growth during the forecast period. The use of the procedures of spinal fusion which are extremely beneficial in trauma surgeries as well as the fractures of complex nature will drive the market growth during the forecast period. In the recent years the trauma cases have grown across the world. These cases can be effectively managed with the help of the bone graft substitutes do to which the market is expected to grow in the coming years.
There is also a growing demand for synthetic substitutes like ceramic as well as polymer. During the forecast period the benefits of the usage of such synthetic substitutes will be helpful in increasing the revenue on the market. The use of synthetic substitutes is extremely beneficial as it helps in lowering the risk which is associated with these kinds of surgeries. The number of complications is also reduced. Different types of materials are used a synthetic substitute. There has been no growth in the preference for these synthetic substitutes especially in the developed nations as there is a high resemblance of these synthetic substitutes with the human bone in terms of the chemical composition. There has been a great positive impact on the revenues generated with the use of synthetic substitutes. In the coming. It is expected that many new products will be launched that will be helpful in creating a greater demand.
Report Coverage | Details |
Growth Rate from 2025 to 2034 | CAGR of 5.94% |
Global Market Size in 2025 | USD 3.38 Billion |
Global Market Size by 2034 | USD 5.68 Billion |
Base Year | 2024 |
Forecast Period | 2025 to 2034 |
Segments Covered | Material, Application, End User, and Geography |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Increasing Prevalence of Orthopaedic Conditions and Musculoskeletal Disorders
The increasing prevalence of orthopedic conditions and musculoskeletal disorders is one of the major factors that are projected to support the rising surge of the global bone grafts and substitutes market. Osteoarthritis, osteoporosis, degenerative disc disease, and traumatic bone injuries are also on the increase, mainly by the virtue of population growth caused by aging, sedentary leisure, and poor diet, coupled with the vast increase in sports and traffic-related injuries.
Such conditions usually lead to loss of bones, broken bones, or even structural deformities, which should be corrected by surgical fusion through bone grafting or bone substitutes. Bone grafts and substitutes are used in the presence of spinal fusions, joint replacements, and fracture repair processes where they protect the missing bone structure and encourage spontaneous bone growth.
High Cost Associated with Products
High costs are one of the significant factors that have inhibited the use of bone graft substitutes market. Such highly developed products as the bioactive ceramics, allografts, and synthetic composites have to undergo extensive processing, quality management, and regulatory consideration, which greatly add to their production cost. Moreover, new technologies applied in the design of grafts, such as 3D printing and biologics, contribute to the cost. In most situations and particularly in low- and middle-income nations, accessibility to these innovative treatments is restricted since the cost is prohibitive to many healthcare providers and patients. Moreover, reimbursement policy that could be limited in some healthcare systems additionally impedes affordability and adoption.
Rising Demand for Minimally Invasive Surgeries
Bone grafts and substitutes are a growing market is largely due to the move toward minimal invasive surgery (MIS). Conventional methods of bone grafting can be difficult to subject to surgical exposure, thus taking a long time to heal, creating high infection rates, and long-term hospital stays. MIS approaches result in less harm to tissues, post-surgery pain, and faster healing. Development of sophisticated bone graft substitute technologies for MIS includes injectable bone fillers, synthetic bone pastes, and bioresorbable scaffolds with the ability to use those agents in a precise manner via small incisions or through catheter-based delivery. The popularity of MIS has only increased with an increasing need to seek less invasive and faster techniques of treatment, particularly among aging citizens and physically active patients.
The hospital segment led the bone grafts and substitutes market and accounted for the largest revenue share in 2024. This dominance has been majorly contributed to the high concentration of orthopedic specialists working in the hospital environment and the increased patients that have been taken through complex bone repair surgery, like; spinal fusions, joint reconstruction, and trauma cases. Hospitals have a hi-tech surgical infrastructure and multidisciplinary teams, and hence support a high volume of orthopedic surgeries that demand orthopedic implants that substitute bone grafts. They can incorporate and use new innovative, biocompatible, and customizable bone graft replacements, and this leads to better patient outcomes.
The specialty clinics segment is expected to grow at a significant CAGR over the forecast period, propelled by the rising development of the clinics prompted by orthopedic specializations in both developed and emerging areas. Such clinics provide a more patient-centred, seamless service focused specifically on musculoskeletal disorders. In general, many are reported to be faster with better patient outcomes than general hospitals. These clinics are becoming well-equipped with the latest imaging, diagnostic equipment, as well as grafting materials, and can manage multiple procedures than previously. Moreover, the specialty clinics can be characterized by increased operational freedom and, consequently, fast adaptation and implementation of the latest treatment plans.
The allograft segment is expected to have a dominant position in the coming years. The allograft segment has dominated the market in the past with the largest market share in terms of revenue. There is a growing demand for allografts due to the benefits offered by the use of this material. The segment is expected to grow as the material is osteoconductive and it is also extremely beneficial in providing quick structural support. These two factors will drive the market growth for the allograft segment during the forecast period. The use of allograft also reduces the need for or different surgery bone. One of the major benefits of it is that the healing process of the wound is faster. The time required for performing the surgery is also less with the use of the allograft material. Allograft saw generally used in knee, spine and hip areas. The availability of the material in different shapes is also expected to drive the market growth during the forecast period. There is a increase in the popularity of the allograft segment as it happens to be osteoinductive and osteo conductive.
The synthetic segment is also expected to have a good amount of market share during the forecast period. When it comes to the use of synthetic material these materials are preferred more by the patients as there is a very limited risk associated with the use of synthetic material for any type of transmission of the disease. Synthetic material is also more biocompatible as compared to the allograft segment. There has been no growth in the demand for ceramics, composites as well as polymers. The growing demand for the ceramic material is largely associated with its quality of being reabsorbed in the human body. The use of ceramic also helps in reducing the chances of contracting any infections or diseases. The time period required for performing the surgery with the use of ceramics is low as compared to the allograft segment due to which the market is expected to grow well during the forecast period. Other benefits associated with the use of synthetic material is lesser pain and less amount of blood loss during the surgery. All of these benefits are expected to drive the market growth during the forecast period.
Global Bone Grafts and Substitutes Market Revenue, by Material (USD Million)
Material | 2022 | 2023 | 2024 |
Allograft | 1,607.1 | 1,690.5 | 1,799.4 |
Synthetic | 1,274.2 | 1,346.4 | 1,423.7 |
Latest Announcement by Industry Leaders
(Source : https://www.bonebiologics.com )
In February 2025, Evergen declared the deployment of a new AI-enabled image processing program to push forward the examination of CT bone graft scans. Hundreds of images can be analyzed by the software, and the results generated in less than a jiffy, which means the processing of bones will be achieved much faster, and a significant number of patients will get life-altering procedures.
In January 2025, Medtronic confirmed that it has entered into an exclusive five-year distribution scope with Kuros to market MagnetOs (bone graft) manufactured by Kuros in selected spine geographic areas within the U.S. market. MagnetOs is a bone graft alternative made of ceramics with a wound fusion of 79 percent, as compared to the handled auto graft of 47 percent, employing the bone of the patient him or herself.
In October 2023, Orthofix Medical Inc. announced that OsteoCoveTM- a breakthrough bioactive synthetic graft received 510k and is commercially launched. Putty and strip form of osteoCove provides superior bone-building capabilities to numerous orthopedic and spine applications.
By Material
By End User
By Geography
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
June 2025
July 2025
July 2025
February 2025